AccuStem Sciences stockholders approve reverse stock split authorization at annual meeting

Accustem Sciences Inc.

Elected directors Wendy Blosser, Gabriele Cerrone, Willy Simon, John Brancaccio with >7M votes each.
Ratified Mazars USA LLP as independent auditor for fiscal year ending Dec 31, 2022.
Approved amendment to certificate of incorporation to effect reverse stock split (1:2 to 1:15) before Oct 10, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.